Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Food and drug colors have always stirred up big debates, but few have a history as tangled as Sunset Yellow Aluminum Lake. Since the late 19th century, synthetic dyes replaced natural coloring agents because natural ones struggled with stability and intensity. Out of the azo dye family, Sunset Yellow FCF came into use across Europe and North America. Around the middle of the last century, technical advances delivered aluminum lake pigments—a result of fixing the water-soluble dye onto an insoluble base. It wasn’t just a chemistry lesson; it shook up the way manufacturers could design long-lasting, bright pharmaceuticals without worrying about dyes bleeding or fading. Regulatory frameworks tightened in the 1960s and ‘70s, with each zone (BP for British Pharmacopeia, EP for European, USP for United States) setting their own tests and standards. Today, the pharma grade isn’t just another bright pigment—its production and use turn on generations of chemistry, regulation, and human health studies.
Pharmaceutical companies don’t pick colorants just for looks. Sunset Yellow Aluminum Lake comes in a powder or sometimes granulated form, highly valued for strong orange-red tones. Being an aluminum lake type, it resists dissolution in water. That matters—and not just for looks. Tablet coatings stay bright after moisture, and gel capsules don’t stain the machinery. Drug brands rely on color to stand out, but the consistency of this colorant gives confidence during batching and packaging.
Manufacturers, lab managers, and even regulators focus on appearance and solubility first. The bright orange pigment won’t dissolve in water, oil, or alcohol—only acids can get it going. That makes handling safer and easier during mass production. The average particle diameter usually ranges from 5 to 25 microns, fine enough for coatings but not so fine as to mess with respiratory safety limits in the plant. It has high tinting strength and vivid hue retention, so even tiny amounts go a long way. Basic chemical composition shows the dye (Sunset Yellow FCF, chemically C16H10N2Na2O7S2) is adsorbed on a hydrated aluminum oxide substrate. The combined product stays inert under normal conditions, with melting points exceeding 300°C and solid chemical bonds that resist light fade and microbial attack.
Each pharmacopoeia lays out test methods for loss on drying, pH, heavy metal limits, and dye content. USP and EP batches cannot have more than 10 mg/kg of lead, arsenic, or mercury—levels documented by heavy scrutiny with ICP-MS or AAS testing. Labeling matters for both regulators and manufacturers: any product containing this colorant must declare it by its INCI or color index number (C.I. 15985:1), include batch and expiry dates, and state all country-specific codes. These rules keep substandard batches or dangerous counterfeits from hitting the market, supporting traceability across global supply chains.
Production starts with Sunset Yellow FCF dye synthesized through diazotization and coupling reactions from basic aromatic compounds. The raw dye gets suspended in water, heated with sodium aluminate, and then neutralized with an acid to form a stable aluminum salt. This process fixes the dye on the aluminum substrate, giving a water-insoluble pigment. Filtration, thorough washing, and drying follow, minimizing any free dye or unwanted by-products. One of the biggest challenges in this work is batch-to-batch consistency; any slip can show up in finished product inspection.
Pharmaceutical-grade production leaves little room for unwanted by-products. Sunset Yellow Aluminum Lake, in its core form, stays stable—neither acidic nor basic environments easily break down the azo bond. Given enough heat and strong acids, the compound can hydrolyze, releasing its constituent ions; that rarely happens in medicines under normal use. Modified versions, sometimes with different particle sizes or dispersants, have entered the supplement and nutraceutical industries. Each tweak means new toxicity studies and fresh regulatory hurdles, though.
Depending on the region and regulatory agency, you may see this pigment called E110 Lake, C.I. 15985 Lake, FD&C Yellow No. 6 Aluminum Lake, or Orange Yellow S Lake. Suppliers sometimes tack on codes like “pharma grade,” “micronized,” or “BP/EP/USP compliant” to match customer needs and official nomenclature. This alphabet soup creates headaches in global sourcing but helps buyers avoid toxic or mislabelled dyes.
Safety matters from factory to pharmacy shelf. Workers handling bulk Sunset Yellow Aluminum Lake must use dust masks and gloves to avoid ingestion or skin contact, as aluminum lakes can irritate mucous membranes. Factories follow GMP, HACCP, and ISO 9001/22000 frameworks—requiring rigorous cleaning, storage in moisture-controlled rooms, and scheduled inspections every shift. Even in the best-run plants, I’ve seen incidents where powder disperses into the air, so managers keep dust collectors and real-time air monitors running. Finished batches can’t ship without passing residue and purity checks. The standards cut risks not just for workers but for vulnerable groups, including kids and pregnant women who may take colored medicines.
In my time working with both food and pharma manufacturers, I’ve seen this pigment show up in chewables, gelatin capsules, effervescents, syrups, and lozenges. Sometimes, it is used to identify strengths of the same drug—one for 10 mg, another for 50 mg. Healthcare providers and patients rely on color as a memory tool, helping avoid dosing mistakes. The aluminum lake form prevents color leaching into adjacent tablets during blister packaging, keeping lines running smoothly and pharmacies free from cross-contamination scares.
R&D teams work to balance color strength, cost, and safety. Current lines of research dig into alternative substrates that reduce aluminum exposure, since some researchers question the safety of long-term aluminum ingestion, even at low doses. Nanotechnology has attracted interest for its ability to make particle sizes more uniform and easier to suspend, but so far, scale-up and regulatory acceptance lag behind. Analytical chemistry innovations, like HPLC-MS/MS, allow tighter quality checkpoints—all boosting safety and building consumer trust in the finished medicines.
No discussion around Sunset Yellow Aluminum Lake escapes talk of safety. Decades of studies point to generally low toxicity at legal intake levels, with liver and kidney effects mainly in animals under massive, unrealistic doses. Some people report allergic reactions (like hives or asthma-type symptoms), so regulators continue to require labeling for transparency. Recent studies explore whether aluminum itself, even in this chemically fixed form, might bioaccumulate in brains or bones; so far, evidence in humans remains limited. Researchers in Italy, Japan, and the US keep checking for DNA damage or oxidative stress, urging continued monitoring as exposure patterns shift with the rise of colored supplements and over-the-counter meds.
Growing consumer pressure for “clean label” ingredients has already led multinationals to start moving away from artificial lakes like Sunset Yellow, especially in kids’ medicines and supplements. Alternatives from natural sources (like beta-carotene or paprika extracts) hold promise, but so far they fall short on light stability and long-term shelf life. I think the biggest advances will come from better encapsulation technologies—locking in colorants with cleaner carriers and using digital batch control to guarantee fine particle size without relying on aluminum. University, government, and industry labs all pool resources to hunt for non-toxic, high-performance colorants, likely leading the next regulatory push. Until better ingredients arrive, there’s little question this pigment and its safety standards will remain in the headline mix for anyone working with color in the pharmaceutical world.
Sunset Yellow Aluminum Lake shows up in pills far more often than most people realize. This colorant, once you get past the long name, serves a straightforward role: giving medications and supplements a bright, orange-yellow hue. The “lake” form stays stable and keeps its vibrance much longer than water-soluble dyes. You get a more attractive, easily identifiable tablet with every dose. In pharmacies and hospitals, color isn’t about looks—it helps patients and healthcare workers tell pills apart, cutting down on mix-ups that could bring serious consequences.
In my own work with pharmacy students, quality standards come up again and again. Drugs that end up on our shelves need to clear strict hurdles before they get approved for use—especially those labeled as BP, EP, or USP grade. These stand for British Pharmacopoeia, European Pharmacopoeia, and United States Pharmacopeia. Each pharmacopeia lays out clear criteria for identity, purity, and safety, designed to keep toxic byproducts or heavy metals out. There’s no room for shortcuts with these benchmarks in place.
Kids take medicine more easily when it doesn’t look dull or scary. Seniors dealing with multiple prescriptions often rely on color cues just to manage daily routines. I’ve watched confusion disappear for patients once a doctor points out, “Take the yellow tablet in the morning.” Color turns into a system that guides safe use, not just a sales trick.
Color additives also help manufacturers brand their products. In a world full of generic pills, looks go a long way in helping people feel confident that they’ve got the right drug in their hands. It’s not simply marketing. Safety improves as mistakes go down.
Sometimes a splash of color stirs up more debate than you’d think. There’s public concern about artificial dyes like Sunset Yellow, sparking questions about hyperactivity and allergies. Research continues, and so far, regulatory agencies have not found enough evidence to ban it from pharma uses. Still, there’s smart pressure for drugmakers to keep doses as low as possible, always updating their processes when new data comes out. It helps to know that pharmaceutical-grade ingredients stay under much stricter surveillance—meaning you’re unlikely to get unsafe amounts through medicine, compared to, say, some imported candies or snacks.
Some stakeholders argue for natural colorants instead. That sounds appealing, but in reality, natural options often bring instability, fading, or bad reactions with active drug compounds. Unless a plant-based dye can survive the manufacturing process and show no risk to patients, change stays slow.
Long-term, investment in cleaner, greener color technology could tip the scale. More research means safer options may come along, but for now, the consistency and safety record of pharmaceutical-grade Sunset Yellow Aluminum Lake give it staying power.
The presence of Sunset Yellow in pharma products brings together science, safety, and practical design. With every colored tablet or capsule, it’s about giving patients what they need: clarity, comfort, and confidence in what they’re taking. It’s not glamorous work, but it matters.
Sunset Yellow Aluminum Lake, or E110, brings a bright orange color that looks lively in tablets, capsules, and syrups. Walk through any pharmacy, you’ll notice medicines that look more appealing because of it. Kids are less likely to spit out an injection or tablet colored with it. It has helped increase patient compliance for decades. So, folks in pharmaceutical labs keep turning to this coloring agent.
Oversight bodies like the US FDA and the European Food Safety Authority haven’t banned it. You can find it in food, drinks, and even personal care products. Both agencies rely on animal studies, human data, and large stacks of evidence before approving ingredients. They’ve set acceptable daily intake (ADI) at 4 mg per kilogram of body weight. With regular pharmaceutical use, that’s rarely exceeded.
People often ask: Does Sunset Yellow trigger allergies, or worse, cause genetic damage? Most people don’t react at all, but a small number have reported hypersensitivity, especially those already sensitive to aspirin or with asthma histories. The British government required warning labels on foods containing the dye, not because it’s especially dangerous, but to help parents make informed choices for children with hyperactivity concerns. Few documented cases show allergic-type reactions to drugs, but it’s much rarer than problems with peanuts, gluten, or penicillin.
Pharmaceutical uses demand a much higher standard for purity. Regulators closely monitor for contaminants (like lead or other heavy metals) that sometimes show up in lakes prepared for food. It pays to make sure every batch tested meets pharmaceutical specifications for residual solvents, particle size, and absence of toxins.
I’ve seen drug manufacturers invest in ultra-pure versions, just to reduce any risk further—even if the source is already cleared for food. This practice protects people with compromised immune systems or anyone who might be sensitive. Whether making paracetamol suspensions for children or vitamin tablets for adults, companies don’t want issues cropping up months down the line.
Old studies from the 1970s and more recent analyses both tried to link food colors to hyperactivity in children. Some parents report behavioral spikes after exposure, but reviews published in journals like The Lancet and statements from major health organizations keep coming to the same conclusion: evidence is mixed at best, with most children showing no effects. Nonetheless, precaution wins out, and labeling laws exist so those who want to steer clear can easily do so.
Modern medicine doesn’t throw around “safe enough” like a magic word. Health authorities keep approving Sunset Yellow for drugs, but they push for transparency and monitoring. Companies should take every report of side effects seriously and make batch testing rigorous. Responsible players already share full ingredient lists with prescribers and consumers online.
Some firms have shifted toward natural pigments like paprika extract or beta-carotene for a growing niche. The trouble comes with stability and consistency—Sunset Yellow performs well in high-heat and moisture-prone formulas where naturals often fall short. Substitution makes sense for low-risk groups who just want “clean label” products, but people with rare allergies or extra-sensitive immune systems will always need clear, honest information to make choices.
Day-to-day work in quality control taught me one thing: details in product specifications shape your results. Missing out on key points can cause entire batches to end up in the waste bin. Take the pharmaceutical field as an example. Raw materials cannot vary much. If they do, the final medication loses reliability. Industries rely on concrete numbers—like particle size, moisture level, and appearance—to cut out guesswork and keep operations predictable.
Purity always sparks debate. A chemical with just a trace element out of place becomes a hazard instead of a help. According to the United States Pharmacopeia, most substances for medicinal use ask for purity of at least 98%. The food industry often sets the bar differently—purity levels must clear a path for both safety and palatability. In rare cases, purity climbs even higher; research laboratories reach for materials and reagents at 99.9%. Impure inputs not only hurt end products but can harm people.
Each new shipment to the plant must clear strict tests. Years of checking certificates and test data left me with zero tolerance for incomplete documentation. Labs measure contaminants using trusted techniques. Spectroscopy, chromatography, and wet chemistry help pick out iron, lead, arsenic, and other heavy metals, often down to the parts-per-million range. Particle size analysis prevents dust explosions or flow issues. Colleagues trained to spot color changes or foreign smells will flag a batch even before results land on a computer screen.
Traceability prevents finger-pointing later. Every manufacturer worth its name keeps a batch record straight through shipping. Real-world experience says even one bad audit can sink business relationships fast. Certification by ISO or FDA sets a chain of trust. I’ve seen suppliers dropped after failing a single, simple test. You keep the chain strong or break it and lose out. Digital records now improve transparency, but nothing beats surprise audits—these still uncover shortcuts or poor handling.
Spec sheets and high purity stop problems at the source. But even so, training factory staff plays a large role. I recall a morning shift where cross-contamination caused hours of downtime and wasted materials. Only extra training and a more detailed cleaning protocol set things right. Companies that want reliability stick to the basics: routine cleaning, calibrated tools, and careful storage conditions. Investing in employee education pays off more than high-tech gear.
Many in the field still cut costs by skipping routine tests, only to watch regulators shut them down. Real investment goes into better sourcing, routine analysis, and honest labeling. If supply chains stretch overseas, regular supplier visits and dual-sourcing catch problems early. Sourcing from certified partners, budgeting for more frequent audits, and refusing loads that miss specs build trust between buyers and sellers.
Tough specifications and rock-solid purity are not bureaucratic hurdles. They protect workers, end users, and long-term business health. Each detail, from the specs on a delivery note to a lab slip, adds up—a product someone can trust, rather than one to worry about. Care, attention, and honesty carry more weight than shortcuts and cheap fixes. That lesson played out time and again.
Working in pharmaceutical quality control for over a decade, I’ve seen the impact of regulatory standards every day. BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) create clear guidelines for safety, purity, and strength in anything used for patient care. These standards shape everything—from the ingredients going into a tablet, to the final batch that reaches the hospital shelf.
Asking if a product complies with these sets of rules carries real weight. Each publication maintains its own monographs, measurements, and acceptable ranges for attributes like particle size, pH, identification, and purity. These aren’t just checkboxes; failing any one of them can stop a product from ever reaching patients. As an industry, any shortcut or oversight here leads directly to trust issues with healthcare providers and the public.
Over the years, I’ve been in audit rooms where regulators point to a tiny deviation in a raw material specification, and production halts until it’s fixed. Real compliance means documentation, traceability, and tests performed using validated methods. Some manufacturers say they “meet standards,” but genuine assurance only comes from seeing audit reports, Certificates of Analysis, and batch records. In my experience, it’s crucial to check that every grade of the product matches not just one, but the latest versions of all required pharmacopeias.
BP, EP, and USP do not always agree on everything. For example, one might list an impurity limit that’s tighter than the others. I remember a project where our raw excipient passed EP and BP tests, but failed USP impurity checks. Sorting out those conflicts took a team effort, not just a spreadsheet. It helps if manufacturers are open about how they handle these differences, and what steps they take to keep up with revisions.
If a product falls short on BP, EP, or USP, the risks aren’t just bureaucratic. It means patients could be at risk, and companies face recalls, legal trouble, and damaged reputations. I’ve seen small supply mistakes turn into months of lost production, costing millions and forcing staff to work overtime just to recover. Healthcare providers want ingredients they can trust, and compliance is their first filter. The connection between regulatory standards and patient safety runs deep.
To keep products in step with these standards, companies should set up regular training, internal audits, and robust change control. Teams that read every update from BP, EP, and USP avoid nasty surprises. Relying on third-party labs for results works, as long as those labs also stay current with each revision. It’s easier to build good compliance habits during product development, instead of scrambling to fix problems in a finished batch.
Most importantly, a culture of transparency between manufacturers, quality teams, and regulators encourages faster problem-solving. I’ve seen suppliers who answer questions honestly and provide paperwork without hesitation—they never made the news for the wrong reasons. Those who cut corners often get caught eventually.
Testing against BP, EP, and USP keeps bad batches out of circulation. This is the main reason companies pour resources into quality systems and staff training. In a world where patient safety is always the bottom line, these standards are more than mandatory—they’re the foundation of trust.
Sunset Yellow Aluminum Lake attracts a lot of attention in the pharmaceutical world. Its vibrant color makes products stand out, but there’s a side most people never see. This ingredient turns up in tablets, capsules, and even syrups, but storing and handling it isn’t as simple as stacking jars on a shelf. Smart storage and careful handling matter because the product’s quality, safety, and the end-user’s trust all depend on what happens before the ingredient ever makes it to a tablet press.
I remember visiting a small pharmaceutical facility in the summer. The place was clean, but the storage for excipients didn’t get much attention. Heat, moisture, and casual handling set powders up for clumping, loss of potency, and even contamination. Sunset Yellow Lake isn’t the kind of product to leave uncapped or in a humid environment. The FDA warns that exposure to moisture can drive chemical changes, and studies link poor storage to disruption in color consistency. If the pigment changes, so can the patient’s experience, not to mention the manufacturer’s reputation.
Proper storage builds confidence in every batch. Pharmacopeias, such as the USP and the European Pharmacopoeia, recommend keeping color additives like Sunset Yellow Aluminum Lake in tightly closed containers. Temperature control is not a luxury—it’s a basic requirement. Storing the lake at 15–30°C (59–86°F) in a cool, dry, and well-ventilated area goes beyond ticking a box; it dramatically enhances shelf life.
Physical separation from raw chemicals, sanitizers, or cleaning supplies keeps cross-contamination in check. Color migration can happen through dust in busy facilities, so sealed containers and dedicated storage shelves matter. I have seen manufacturers use color-coded bins and clear labels, and the organization of a storage room often tells you everything you need to know about a company’s quality culture.
Those handling Sunset Yellow Lake should treat it as more than a background ingredient. Wearing gloves, masks, and eye protection during weighing and transfer routines cuts down the risk of accidental spills and skin contact. People often overlook powder dispersal, but airborne dust can trigger allergic reactions and contaminate other materials. Good manufacturing practice (GMP) guidelines require regular surface cleaning and responsible disposal of spilled or outdated material.
Training plays a central role. I’ve noticed that teams with strong training programs make fewer mistakes and show more respect for basic protocols—down to making sure they never transfer scoops or spatulas from one container to another. Small habits make a real difference, especially since Sunset Yellow Lake can stain surfaces and is tough to remove from porous materials.
Solutions aren’t complicated, but they demand discipline. Facilities can install data loggers in storage rooms to monitor temperature and humidity. Written records not only safeguard against mistakes, but also meet regulatory standards and protect the company in an audit. Regular inventory checks help remove expired or compromised materials. Some manufacturers take it a step further, sealing products in nitrogen-flushed containers for longer-term stability.
Managers and technicians who recognize the value of quality at every step build trust with customers and regulators. A little attention to detail—right from storage to handling—translates into safer, more reliable products and, most importantly, healthier outcomes for patients relying on those bright-colored tablets each day.
| Names | |
| Preferred IUPAC name | Disodium 6-hydroxy-5-[(4-sulfophenyl)azo]-2-naphthalenesulfonate, aluminum complex |
| Other names |
CI 15985:1 FD&C Yellow 6 Lake Orange Yellow S Lake E110 Lake Sunset Yellow FCF Aluminum Lake |
| Pronunciation | /ˈsʌn.sɛt ˈjɛl.oʊ əˈluː.mɪ.nəm leɪk ˌbiːˈpiː ˌiːˈpiː ˌjuːˌɛsˈpiː ˈfɑːr.mə ɡreɪd/ |
| Identifiers | |
| CAS Number | [68583-95-9] |
| Beilstein Reference | 3913796 |
| ChEBI | CHEBI:86321 |
| ChEMBL | CHEMBL: CHEMBL3834933 |
| ChemSpider | 21581897 |
| DrugBank | DB13911 |
| ECHA InfoCard | 07f1d5a4-2766-48be-901a-0c6d8d5ab5c3 |
| EC Number | 132-001-1 |
| Gmelin Reference | 871874 |
| KEGG | C01676 |
| MeSH | D005897 |
| PubChem CID | 5280380 |
| RTECS number | XF4170000 |
| UNII | 4JF2LE7AG8 |
| UN number | UN1544 |
| CompTox Dashboard (EPA) | DTXSID7020182 |
| Properties | |
| Chemical formula | C16H10N2Na2O7S2·xAl(OH)3 |
| Molar mass | 452.36 g/mol |
| Appearance | Bright orange to yellow-orange powder |
| Odor | Odorless |
| Density | 0.60 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 3.12 |
| Vapor pressure | Negligible |
| Acidity (pKa) | Acidity (pKa): 11.6 |
| Basicity (pKb) | 8.4 |
| Dipole moment | 0 D |
| Pharmacology | |
| ATC code | A16AX30 |
| Hazards | |
| Main hazards | May cause respiratory irritation. May cause eye irritation. May cause skin irritation. |
| GHS labelling | GHS labelling: Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008 (CLP/GHS) |
| Pictograms | GHS07", "GHS09 |
| Signal word | Warning |
| Hazard statements | H317: May cause an allergic skin reaction. |
| Precautionary statements | P264, P270, P273, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-0-0-NA |
| Lethal dose or concentration | LD50 (Rat, oral): > 2,000 mg/kg |
| LD50 (median dose) | > LD50 (median dose): >2000 mg/kg (oral, rat) |
| NIOSH | QT0408000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 2.5 mg/kg |
| Related compounds | |
| Related compounds |
Sunset Yellow FCF Sunset Yellow Lake Tartrazine Ponceau 4R Allura Red AC Amaranth Brilliant Blue FCF Erythrosine Quinoline Yellow Carmoisine |
Chengguan District, Lanzhou, Gansu, China
